Now accepting Scholarship Applications. All applications must be post marked by April 3, 2020
Odenville Drugs Logo

Get Healthy!

Results for search "Multiple Sclerosis".

02 Jul

Multiple Sclerosis and Cancer Risk

MS patients may have a higher risk of developing certain cancers.

Health News Results - 44

Mindfulness training may help counter the thinking and emotional difficulties caused by multiple sclerosis.

In a small test study, people with multiple sclerosis (MS) who had four weeks of mindfulness training emerged with better emotional control and faster thinking.

Multiple sclerosis is a disease in which the immune system attacks the brain, spinal cord and optic nerves....

Air pollution might increase the risk for multiple sclerosis (MS), Italian researchers report.

They found that in places with low levels of tiny particles of air pollution called particulate matter, the risk for MS was lower than in areas where those levels were high. In urban areas, the risk was 29% higher than in rural areas.

"Our findings show that the prevalence of...

A new blood test might help doctors predict whether someone's multiple sclerosis may soon get worse.

The test looks for a substance called neurofilament light chain. It's a nerve protein that can be detected when nerve cells die. People with higher levels of it were more likely to have worsening MS effects within the next year.

"In a disease like MS that is so unpredictabl...

Multiple sclerosis can cause weakness, pain, fatigue and vision problems. The disease also appears to increase the odds of heart disease and stroke, new research suggests.

Multiple sclerosis (MS) is a central nervous system disorder that can affect movement. The British study found that people with MS were nearly one-third more likely to have "macrovascular disease." Those are condit...

Brain inflammation may be more of a factor in dementia than previously believed, a new British study suggests.

"We predicted the link between inflammation in the brain and the buildup of damaging proteins, but even we were surprised by how tightly these two problems mapped on to each other," said co-author Thomas Cope of the Department of Clinical Neurosciences at the University of Ca...

A new discovery could lead to better treatments for multiple sclerosis (MS) and other autoimmune diseases, such as psoriasis and rheumatoid arthritis, researchers report.

MS occurs when immune cells get into the central nervous system (the brain and spinal cord), causing nerve damage that results in neurological problems. However, the cause is unclear.

Studies in a mouse mo...

Most people take the ability to move for granted, but not Kathy Miska.

Miska has had multiple sclerosis for two decades now, and her ability to get around has deteriorated steadily.

Now, a new robotic exoskeleton is giving her an opportunity to regain some of the mobility she's lost to the degenerative nerve disease.

"You can definitely tell when you get out of the suit....

The cost of essential medications for multiple sclerosis have nearly tripled this decade, despite the release of the first generic MS drug, a new study shows.

The 2015 release of glatiramer acetate -- the generic version of Copaxone -- did nothing to halt skyrocketing prices for MS medications, said lead researcher Daniel Hartung. He's an associate professor of pharmacy with Oregon St...

Women with multiple sclerosis often find that their symptoms ease during pregnancy. And evidence is growing that breastfeeding might have a similar benefit.

A new review of 16 studies found that overall, women with MS who breastfed were 37% less likely to have a relapse within a year of giving birth, versus those who bottle-fed.

The findings do not prove breastfeeding is...

If you have a neurological disorder, a video chat with your doctor might be as good as an office visit for checking on your condition.

That's the conclusion of researchers who analyzed 101 studies on telemedicine use for concussion, traumatic brain injury, dementia, epilepsy, headache, multiple sclerosis, movement disorders, neuromuscular conditions and general neurology.

In...

The first generic versions of the multiple sclerosis drug Gilenya have been approved by the U.S. Food and Drug Administration.

The three generic versions of Gilenya (fingolimod) capsules were approved for the treatment of relapsing forms of multiple sclerosis (MS) in adults.

"Approving safe and effective generics so patients have more treatment options continues to be a prio...

A variant of a common herpes virus may play a role in the development of multiple sclerosis (MS), Swedish researchers say.

They analyzed the blood of about 8,700 MS patients and a control group of more than 7,200 people without MS. They were looking for antibodies against proteins of two variants (A and B) of human herpesvirus 6 (HHV-6), which has been linked with MS.

MS pat...

If you have multiple sclerosis (MS), you can and should receive recommended vaccinations -- including annual flu shots, a new American Academy of Neurology guideline says.

"We reviewed all of the available evidence, and for people with MS, preventing infections through vaccine use is a key part of medical care," said guideline lead author Dr. Mauricio Farez.

"People with MS ...

Medicare patients with multiple sclerosis (MS) saw their medication costs soar by more than sevenfold over a decade, a new study finds.

It's no secret that the costs of MS drugs have skyrocketed in recent years. When the first so-called disease-modifying drugs were approved starting in the 1990s, they cost roughly $8,000 to $11,000 per year, according to the National Multiple Sclerosi...

"Smoldering" spots in the brains of multiple sclerosis patients may signal more aggressive and disabling forms of the disease, researchers report.

Their finding may help test the effectiveness of new treatments for these types of MS.

The investigators used specialized brain scans to examine the brains of hundreds of MS patients and identified dark-rimmed spots that represent...

Surgery is safe for people with multiple sclerosis (MS), a new study finds.

"The idea that patients with MS might be at an increased risk of relapse following surgery isn't necessarily the case, so we need to be careful delaying important surgeries," said study first author Dr. Lindsey De Lott. She is an assistant professor of neurology at the University of Michigan, in Ann Arbor.

...

Obese children may be twice as likely to develop multiple sclerosis, a new study suggests.

And once obese children are diagnosed, they tend to have a poorer response to their initial treatment than average-weight kids do.

Multiple sclerosis (MS) is a neurological disorder caused by a misguided immune system attack on the body's myelin -- the protective sheath around nerve fi...

MONDAY, July 1, 2019 (HealthDay News) -- Multiple sclerosis is a tough disease to manage and live with, but a new, long-running Norwegian study suggests it might also raise cancer risk.

Overall, the higher risk was small -- just 12%. However, the risk of certain cancers -- such as central nervous system (brain, spinal cord and optic nerve) cancers and urinary cancers were around ...

Obesity can worsen multiple sclerosis symptoms, researchers say.

Their study involved 140 patients with the relapsing-remitting form of MS, which means patients have periods of attacks (relapses), followed by periods of remission with no or few symptoms. The researchers found that obesity at the time of diagnosis was associated with more severe disability.

The reason: incre...

Multiple sclerosis, epilepsy and Parkinson's can be physically taxing conditions, but new research shows they exact a huge financial toll as well.

Over a 12-year period, out-of-pocket costs for Americans with these illnesses jumped, with the biggest increase seen among people with multiple sclerosis (MS). Those patients paid 20 times more for their drugs in 2016 than they did in 2004...

Almost one in five multiple sclerosis patients may be misdiagnosed with the autoimmune disease, according to a new study.

Of 241 previously diagnosed multiple sclerosis (MS) patients referred to two major Los Angeles medical centers for treatment, nearly 18% did not actually have the autoimmune disease, the researchers found.

Those patients spent an average of nearly fou...

The U.S. Food and Drug Administration has approved another new multiple sclerosis drug -- the second in one week.

Mavenclad (cladribine) pills can be used to treat relapsing forms of MS in adults, including relapsing-remitting disease and active secondary progressive disease. The drug is not recommended for MS patients with a course of the disease known as clinically isolated syndrome...

An older but still common multiple sclerosis (MS) treatment has an unexpected perk: It not only quells symptoms, but patients may also live longer.

New research revealed that patients taking a beta interferon drug for more than three years were likely to live longer than those who took one for a shorter time or who didn't take one at all.

"This study was the first and large...

A new pill for relapsing forms of multiple sclerosis (MS) has won approval from the U.S. Food and Drug Administration.

Generally, relapsing MS involves periods of worsening symptoms followed by recovery periods. Over time, some disability follows independent of relapses, and this is called secondary progressive multiple sclerosis, or SPMS.

Approval of the medication Mayzent (s...

Proper treatment can help people with multiple sclerosis (MS) contend with their disease, an expert says.

"Patients get a predisposed feeling that their life is doomed. That it's going to be a complicated life, which isn't necessarily so," said Dr. Cary Twyman, a neurologist at Penn State Health.

"There are many misconceptions and false information about MS on the internet, ...

Research has suggested that kids who enter puberty early appear to face an increased risk of developing multiple sclerosis (MS) as adults.

But a new study asserts that it's actually the excess weight these kids carry around that might raise their odds for MS.

"Although we did see that people who enter puberty at an earlier age were more likely to develop MS, once we factor i...

A new study challenges the long-held belief that multiple sclerosis (MS) can flare up right after pregnancy in women with the relapsing-remitting form of the disease.

In that type of MS, symptoms arise, then go into periods of remission.

"These results are exciting, as MS is more common among women of childbearing age than in any other group," explained study author Dr. Anne...

Popping open too many sodas or other sweetened beverages each day might worsen symptoms for people with multiple sclerosis, new research suggests.

It's important to note that the small study could only point to an association -- it couldn't prove that high soda intake causes MS symptoms to get worse.

But study author Dr. Elisa Meier-Gerdingh said it couldn't hurt to cut back...

Fatigue can plague many people with multiple sclerosis (MS). But a small new study suggests a soothing cup of hot cocoa may bring some relief.

Like dark chocolate, cocoa is rich in flavonoids, which are abundant in fruit and vegetables and have been linked with anti-inflammatory properties, explained researcher Shelly Coe, of the Center for Nutrition and Health at Oxford Brookes Univ...

Medicare rule changes could trigger a spike in out-of-pocket drug costs for patients with multiple sclerosis (MS).

Due to rules that restrict access and require patients to cover more of the cost, those without low-income subsidies can expect to spend almost $6,900 a year out of pocket for MS medicines, researchers reported.

"It's a dysfunctional market that lacks the typica...

A stem cell transplant may help some people with multiple sclerosis (MS) when standard drugs fail, a new clinical trial finds.

The study focused on 110 patients with aggressive cases of MS: Their symptoms had flared up at least twice in the past year despite taking standard medication, and they'd already tried an average of three of those drugs.

Researchers randomly assigned...

An immune system drug may help prevent or slow complications in a type of multiple sclerosis known as secondary progressive MS, a new study finds.

The medication is called rituximab (Rituxan). It's used to treat a number of conditions, including certain blood cell cancers and the autoimmune condition rheumatoid arthritis.

The new Swiss study found that MS patients tak...

Researchers say they've identified a potential link between food allergies and flare-ups of multiple sclerosis.

"Our findings suggest that MS patients with allergies have more active disease than those without, and that this effect is driven by food allergies," said study author Dr. Tanuja Chitnis, an MS specialist, and colleagues.

Multiple sclerosis is a disease of the cen...

A new warning has been added to the multiple sclerosis drug Lemtrada (alemtuzumab) after rare reports of patients suffering strokes and tears in the lining of the arteries in the head and neck, the U.S. Food and Drug Administration said.

Most patients with these problems -- which can lead to permanent disability and death -- developed symptoms within a day of receiving an initial infu...

Although the findings are so far only in mice, studies suggest that aspirin -- even the "low-dose" variety -- might help counter multiple sclerosis.

Multiple sclerosis (MS) is an autoimmune disorder where aberrant immune system T-cells attack and destroy the protective myelin protein sheath that coats nerves.

This causes gradual debilitation for the more than 2.3 million peo...

Medical products derived from marijuana might have a mild benefit in treating symptoms of multiple sclerosis, based on reports from patients.

Drugs containing the major chemical compounds in cannabis are associated with a limited and mild reduction in muscle contractions, bladder dysfunction and pain, based on patient self-assessments from clinical trials included in a major new evide...

Living with a potentially disabling condition like multiple sclerosis (MS) can be difficult, but new research suggests patients get better at dealing with it over time.

"There's an aging paradox in healthy adults. We expect people who are older to be more depressed and anxious because of aging processes [such as physical aches and pain and losing friends and family], but instead, peo...

Researchers say the first drug for children with multiple sclerosis vastly outperformed another common MS medication in a new clinical trial.

Fingolimod (Gilenya) reduced relapse rates by 82 percent in patients aged 10 to 17 compared with interferon beta-1a, a drug commonly used to slow the progression of the degenerative nerve disease.

Nearly 86 percent of children on fingo...

A drug that has long been used in Japan for asthma may slow down brain shrinkage in people with progressive multiple sclerosis, a preliminary trial has found.

The study, published Aug. 30 in the New England Journal of Medicine, tested an oral drug called ibudilast. It is not approved in the United States, but has been used for years in Japan as a treatment for asthma and for ve...

A new subtype of multiple sclerosis (MS) has been identified by researchers, and the discovery changes understanding of the disease.

MS has long been considered a disease of the brain's white matter, where immune cells destroy the fatty protective covering (myelin) on nerve cells. The destruction of myelin (demyelination) is linked to nerve cell death that leads to progressive disabi...

Pain, sleep problems and mental health disorders are common in the five years before someone is diagnosed with multiple sclerosis, a new study reveals.

Knowing about these symptoms could help doctors diagnose and start treating MS earlier, possibly slowing the damage it causes to the brain and spinal cord, says a Canadian team of researchers.

"The existence of such 'warning ...

People with multiple sclerosis (MS) often live with uncertainty because it's hard to predict how quickly the disease will progress and how disabling it might become.

But researchers hope a new MRI test that tracks iron levels in the brain will help answer those questions.

The test -- called quantitative susceptibility mapping (QSM) -- looks at different areas of the brain a...

Vitamin D does little to defend your brain against multiple sclerosis, Parkinson's disease or Alzheimer's disease, a new review shows.

The finding is based on an analysis of more than 70 studies.

"Our work counters an emerging belief held in some quarters suggesting that higher levels of vitamin D can impact positively on brain health," said study author Krystal Iacopetta, ...

A triple whammy of genetics, smoking, and exposure to paints and solvents at work puts a person at extremely high risk of developing multiple sclerosis, Swedish researchers report.

On its own, any one factor elevates the risk for the central nervous system disease substantially, the investigators said. But when all three factors line up, the risk jumps 30-fold.

"This is a no...

Show All Health News Results